**4.6 Discharge**

Advice regarding safe and supported discharge is available [14]. Patients using insulin pumps or wearable diabetes technology should have them returned to the patient if not being used and ensure enough consumables are available at home. If a patient has had DKA, SGLT2i should not be used. Metformin can be re-started once the patient is well, eGFR>30 ml/min and lactate is normal. Sulphonylureas may have been withheld due to risk of hypoglycaemia, and assessment should be made if re-starting it is appropriate.

## **4.7 Outpatient management**

It is suggested that patients with diabetes (PWD) not yet infected with the SARS-CoV-2 virus should intensify their treatment to prevent COVID-19 infection including glycaemic control, management of hypertension and raised cholesterol. Tele medicine and virtual appointments should continue to ensure adequate follow up [15]. The priority was to contain spread of COVID-19 but health care services need to ensure that the needs of PWD are met is imperative which includes continuous supply of medications and available healthcare services in the primary care [32].

## **4.8 Prevention**

Patients with COVID-19 infection without diabetes should be monitored for new onset diabetes especially if on steroids. PWD and COVID-19 infection should have good glycaemic control [15].
